OBJECTIVE
Non-alcoholic steatohepatitis (NASH) is one entity in the spectrum of non-alcoholic fatty liver disease (NAFLD). The aim of this study was to explore the prevention and therapeutic effect of sophocarpine on experimental rat NASH.
METHODS
Sophocarpine with the dosage of 20 mg/kg/day was